1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Patient information
Patient Age (Years)/Sex Pathology Tumor Resection Volume (mL) WBNAA mmol/L MD (mm2s−1) Clinical Follow-up: Status, Time Elapsed Since Surgery 1 55/M Anaplastic Mixed GGNC (III) 45 8.4 1.068 Deceased, 6 months 2 49/F GBM (IV) 59 9.5 .940 Deceased, 12 months 3 35/M GBM (IV) 99 10.7 .923 Deceased, 12 months 4 37/M Mixed GN (II) N/A 8.6 .953 Stable, 17 months 5 30/M Mixed GN (II) 9 9.2 .982 Stable, 15 months 6 23/F GGNC-DNT (I) 32 12.6 .894 Stable, 10 months 7 39/F Mixed GN (II) 37 12.2 .917 Stable, 12 months 8 74/M GBM (IV) 75 7.8 1.065 Deceased, 9 months 9 62/M Anaplastic GGNC (III) 41 7.9 1.009 Stable, 10 months 10 32/F Mixed GGNC (II) N/A 9.8 .872 Stable, 12 months
Note:—WBNAA indicates whole-brain N-acetylaspartate; MD, mean diffusivity; GGNC, ganglioglioneurocytoma; DNT, dysembryoplastic neuroepithelial tumor; GN, glioneurocytoma; DFA, diffuse fibrillary astrocytoma; GBM, glioblastoma multiforme; N/A, below our measurement sensitivity of 9 cm3.